TheProfitWatch

LUCD - Lucid Diagnostics Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.02 0.04 (3.92%) 0.0 (0.0%) 0.01 (0.47%) 0.01 (0.47%) 0.0 (0.0%) 0.05 (4.43%) -0.01 (-0.96%) 0.0 (0.02%)

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

Category: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.08
Diluted EPS:
-0.08
Basic P/E:
-13.25
Diluted P/E:
-13.25
RSI(14) 1m:
50.0
VWAP:
1.06
RVol:

Events

Period Kind Movement Occurred At

Related News